Cell Therapy News/Articles, page-219

"It's a brave man to call history, when we haven't even left the port yet."

Er... this company, in its previous incarnation, Angioblast Systems, has been at it for the better part of a decade-and-a-half.

That's quite some time to spend in the "port".

Maybe you - unlike a great many before you - will end up being the lucky one who has come on board just as the ship is about to leave the port (although under what power it will do so is still unclear).


"Lets revisit this in a few years before you smugly try claim victory."

Interesting that your view that this is some kind of competition between holders and non-holders. I see myself in no competition with anyone; all I seek to do is preserve the value of my capital.

And if, in a few years' time, MSB ends up being a commercial success, I am sure that there will be nothing to prevent me buying shares in the business and enjoying many subsequent years of growth in Revenue, Profits, Cash Flows and Dividends. Like CSL.

So, other than a "victory" of avoiding permanent capital loss, I am not sure what other "victory" there is to be claimed by anyone.